-

Milliman analysis: Corporate pension funded ratio rises to 103.4% in April despite investment losses

Milliman PFI plans mark four straight months of funding status improvements

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the results of its latest Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans.

During April, the Milliman 100 PFI funded ratio improved from 102.2% at the end of March to 103.4% as of April 30. Rising discount rates again drove this result, as they increased 44 basis points, from 5.24% in March to 5.68% in April and reduced plan liabilities by $60 billion. This offset April’s investment returns of -3.00%, which reduced the market value of PFI plan assets by $46 billion.

“April’s investment performance was the worst of the year so far, and we would not typically expect to see a funding improvement in a month with 3% losses,” said Zorast Wadia, author of the PFI. “But with discount rates soaring 44 basis points for the period, the liability reduction far outweighed the drop in assets, resulting in further progress for the plans toward a funding surplus and enhancing the risk-management options available to plan sponsors.”

Looking ahead, under an optimistic forecast with rising interest rates (reaching 6.08% by the end of 2024 and 6.68% by the end of 2025) and annual asset returns of 10.4%, the funded ratio would climb to 111% by the end of 2024 and 124% by the end of 2025. Under a pessimistic forecast with similar interest rate and asset movements (5.28% discount rate at the end of 2024 and 4.68% by the end of 2025 and 2.4% annual returns), the funded ratio is projected to decline to 97% by the end of 2024 and 88% by the end of 2025.

To view the complete Pension Funding Index, go to www.milliman.com/pfi. To see Milliman’s full range of annual Pension Funding Studies, go to https://www.milliman.com/en/retirement-and-benefits/pension-funding-studies. To receive regular updates of Milliman’s pension funding analysis, contact us at pensionfunding@milliman.com.

About Milliman

Milliman is among the world's largest providers of actuarial and related products and services. The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. For further information, visit milliman.com.

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

Milliman, Inc.


Release Summary
Milliman has just released the latest monthly results of our Pension Funding Index.
Release Versions

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

More News From Milliman, Inc.

Milliman analysis: Corporate pension funding levels rise for eighth consecutive month in November

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans. During November, the PFI funded ratio edged up from 107.0% at the end of October to 107.1% as of November 30. A 1-basis-point rise in discount rates, to 5.34% in November, drove this result. It shaved $3 billion from plan liabilities and offset market returns of only 0.44%. As o...

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...
Back to Newsroom